Ellen H.M. Moors

4.0k total citations
101 papers, 2.6k citations indexed

About

Ellen H.M. Moors is a scholar working on Strategy and Management, Economics and Econometrics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ellen H.M. Moors has authored 101 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Strategy and Management, 20 papers in Economics and Econometrics and 13 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ellen H.M. Moors's work include Innovation and Knowledge Management (16 papers), Pharmaceutical Economics and Policy (11 papers) and Biosimilars and Bioanalytical Methods (10 papers). Ellen H.M. Moors is often cited by papers focused on Innovation and Knowledge Management (16 papers), Pharmaceutical Economics and Policy (11 papers) and Biosimilars and Bioanalytical Methods (10 papers). Ellen H.M. Moors collaborates with scholars based in Netherlands, Slovenia and United Kingdom. Ellen H.M. Moors's co-authors include Wouter Boon, Huub Schellekens, Fiona M. Jucker, Hans A. Heus, Arthur Pardi, Ping Yip, Philip J. Vergragt, Peter J.K. van Meer, Karel Mulder and Ruud Smits and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature Biotechnology and PLoS ONE.

In The Last Decade

Ellen H.M. Moors

99 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ellen H.M. Moors Netherlands 29 493 430 364 305 213 101 2.6k
Min Song South Korea 30 873 1.8× 126 0.3× 147 0.4× 81 0.3× 87 0.4× 230 4.2k
Johan Albert Wallin Denmark 9 118 0.2× 265 0.6× 209 0.6× 103 0.3× 61 0.3× 16 2.8k
Arun K. Jain India 36 320 0.6× 395 0.9× 716 2.0× 89 0.3× 617 2.9× 265 6.4k
Paul Wouters Netherlands 30 172 0.3× 324 0.8× 394 1.1× 163 0.5× 57 0.3× 109 6.2k
Wouter Boon Netherlands 33 87 0.2× 568 1.3× 489 1.3× 467 1.5× 103 0.5× 95 3.1k
David Francis United Kingdom 30 464 0.9× 872 2.0× 408 1.1× 488 1.6× 41 0.2× 104 4.2k
Theo Papaioannou Greece 30 233 0.5× 276 0.6× 273 0.8× 306 1.0× 149 0.7× 136 3.4k
Erjia Yan United States 29 304 0.6× 260 0.6× 218 0.6× 108 0.4× 23 0.1× 84 3.5k
Yoshiyuki Takeda Japan 24 317 0.6× 315 0.7× 226 0.6× 264 0.9× 54 0.3× 64 2.5k
Massimo Riccaboni Italy 32 316 0.6× 1.0k 2.4× 2.0k 5.5× 697 2.3× 43 0.2× 152 4.3k

Countries citing papers authored by Ellen H.M. Moors

Since Specialization
Citations

This map shows the geographic impact of Ellen H.M. Moors's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen H.M. Moors with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen H.M. Moors more than expected).

Fields of papers citing papers by Ellen H.M. Moors

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen H.M. Moors. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen H.M. Moors. The network helps show where Ellen H.M. Moors may publish in the future.

Co-authorship network of co-authors of Ellen H.M. Moors

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen H.M. Moors. A scholar is included among the top collaborators of Ellen H.M. Moors based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen H.M. Moors. Ellen H.M. Moors is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nap, Henk Herman, et al.. (2024). Making Co-Design More Responsible: Case Study on the Development of an AI-Based Decision Support System in Dementia Care. JMIR Human Factors. 11. e55961–e55961. 4 indexed citations
2.
Nap, Henk Herman, et al.. (2024). Embedding responsible innovation into R&D practices: A case study of socially assistive robot development. SHILAP Revista de lepidopterología. 19. 100091–100091. 2 indexed citations
3.
Nap, Henk Herman, et al.. (2024). AI-Assisted Decision-Making in Long-Term Care: Qualitative Study on Prerequisites for Responsible Innovation. PubMed. 7. e55962–e55962. 8 indexed citations
4.
Kienhuis, Anne S., Cyrille Krul, Jacqueline van Engelen, et al.. (2024). The Virtual Human Platform for Safety Assessment (VHP4Safety) project: Next generation chemical safety assessment based on human data. ALTEX. 42(1). 111–120. 2 indexed citations
5.
Ferreira, Guilherme S., Désirée H. Veening-Griffioen, Wouter Boon, et al.. (2023). Translatability of preclinical to early clinical tolerable and pharmacologically active dose ranges for central nervous system active drugs. Translational Psychiatry. 13(1). 74–74. 3 indexed citations
6.
Amaratunga, Chanaki, Phaik Yeong Cheah, Rakiswendé Serge Yerbanga, et al.. (2023). The impact of anti-malarial markets on artemisinin resistance: perspectives from Burkina Faso. Malaria Journal. 22(1). 269–269. 5 indexed citations
7.
Bolarinwa, Oladimeji Akeem, Olugbenga Ayodeji Mokuolu, Jean‐Bosco Ouédraogo, et al.. (2023). Ethical, regulatory and market related aspects of deploying Triple Artemisinin-Based Combination Therapies for malaria treatment in Africa. 1 indexed citations
8.
Boon, Wouter, et al.. (2021). A Research Pathway Model for evaluating the implementation of practice-based research: The case of self-management health innovations. Research Evaluation. 31(1). 24–48. 1 indexed citations
9.
Nap, Henk Herman, Alexander Peine, Wouter Boon, et al.. (2021). Toward Responsible Artificial Intelligence in Long-Term Care: A Scoping Review on Practical Approaches. The Gerontologist. 63(1). 155–168. 40 indexed citations
10.
Moors, Ellen H.M., et al.. (2021). Market Formation in a Global Health Transition. Environmental Innovation and Societal Transitions. 40. 40–59. 11 indexed citations
11.
Dekker, Stefan C., Aletta D. Kraneveld, Jerry van Dijk, et al.. (2020). Towards Healthy Planet Diets—A Transdisciplinary Approach to Food Sustainability Challenges. SHILAP Revista de lepidopterología. 11(2). 21–21. 9 indexed citations
12.
Ferreira, Guilherme S., Désirée H. Veening-Griffioen, Wouter Boon, et al.. (2019). A standardised framework to identify optimal animal models for efficacy assessment in drug development. PLoS ONE. 14(6). e0218014–e0218014. 40 indexed citations
13.
Veening-Griffioen, Désirée H., Guilherme S. Ferreira, Peter J.K. van Meer, et al.. (2019). Are some animal models more equal than others? A case study on the translational value of animal models of efficacy for Alzheimer's disease. European Journal of Pharmacology. 859. 172524–172524. 39 indexed citations
14.
Ebbers, Hans C., et al.. (2012). A Cohort Study Exploring Determinants of Safety-Related Regulatory Actions for Biopharmaceuticals. Drug Safety. 35(5). 417–427. 6 indexed citations
15.
Boenink, Marianne, et al.. (2011). Assessing the Sociocultural Impacts of Emerging Molecular Technologies for the Early Diagnosis of Alzheimer′s Disease. International Journal of Alzheimer s Disease. 2011(1). 184298–184298. 5 indexed citations
16.
Schellekens, Huub & Ellen H.M. Moors. (2010). Clinical comparability and European biosimilar regulations. Nature Biotechnology. 28(1). 28–31. 66 indexed citations
17.
Boon, Wouter & Ellen H.M. Moors. (2008). Exploring emerging technologies using metaphors – A study of orphan drugs and pharmacogenomics. Social Science & Medicine. 66(9). 1915–1927. 58 indexed citations
18.
Lakeman, Phillis, et al.. (2007). Implementation of preconceptional carrier screening for cystic fibrosis and haemoglobinopathies: A sociotechnical analysis. Health Policy. 83(2-3). 277–286. 28 indexed citations
19.
Boon, Wouter, et al.. (2006). Interactive learning in functional genomics innovations. Utrecht University Repository (Utrecht University). 2 indexed citations
20.
Moors, Ellen H.M., A. B. Johan Groeneveld, Erika Timmer, et al.. (1992). Monoclonal antibody MON-114: detection of a marker for neuroendocrine differentiation in human lung cancer. Cancer Letters. 63(1). 61–66. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Min Song Breakdown of academic impact, for papers by Johan Albert Wallin Breakdown of academic impact, for papers by Arun K. Jain Breakdown of academic impact, for papers by Paul Wouters Breakdown of academic impact, for papers by Wouter Boon Breakdown of academic impact, for papers by David Francis Breakdown of academic impact, for papers by Theo Papaioannou Breakdown of academic impact, for papers by Erjia Yan Breakdown of academic impact, for papers by Yoshiyuki Takeda Breakdown of academic impact, for papers by Massimo Riccaboni
Rankless by CCL
2026